[Asia Economy Reporter Minwoo Lee] Chong Kun Dang announced on the 10th that it has obtained a patent for a "formulation containing telmisartan or its pharmaceutically acceptable salts with improved habit and dissolution rate." Through this, the company plans to secure intellectual property rights (IP) for the Telminubo tablet composition and strengthen the competitiveness of its products.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing